Form 4: H.B. Fuller CFO Exercises Options, Sells Shares
Insider Transaction Report
H.B. Fuller's Executive VP and CFO, John J. Corkrean, exercised stock options and subsequently sold a portion of his common stock holdings.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller Co. (FUL), engaged in several transactions involving company securities.
- Exercised 16,672 employee stock options at an exercise price of $43.48 per share on October 27, 2025.
- Sold 14,222 shares of common stock at a weighted average price of $60.3125 per share on October 27, 2025. The sale prices ranged from $60.02 to $60.9350.
- Acquired 153.29 phantom units at a price of $61.49 per unit on October 24, 2025, which convert into common stock on a 1-for-1 basis.
- Following these transactions, beneficial ownership of common stock is 54,646 shares and 27,090.12 phantom units.
- Several employee stock options and restricted stock units remain outstanding with various vesting and expiration dates.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions (option exercise and share sale) which are common for executives. The transactions are profitable for the insider, but do not indicate a significant positive or negative shift in company outlook.
Positives
- Exercised stock options at a lower price ($43.48) and sold shares at a higher market price ($60.3125), indicating a profitable transaction for the insider.
- Acquisition of 153.29 phantom units, which convert to common stock, increases the insider's long-term equity interest in the company.
- Accumulation of additional phantom units and restricted stock units through dividend equivalent features demonstrates continued equity growth.
Negatives
- The sale of 14,222 shares of common stock reduces the insider's direct equity holding, although this is a common practice for executives to manage personal finances or cover taxes associated with option exercises.
Future Outlook
This Form 4 filing does not contain explicit forward-looking statements or guidance from the company.
Industry Context
This filing reports routine insider transactions and does not provide information relevant to broader industry trends or competitor analysis.
Stakeholder Impact
- Shareholders: Routine insider transactions typically have minimal direct impact on other shareholders. The sale could be interpreted as a slight reduction in insider direct equity holding, but it is a common practice for executives to manage personal finances or cover taxes associated with option exercises.
- Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.
Next Steps
- Future vesting of various outstanding employee stock options and restricted stock units on their respective schedules.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date exercisable for 16,672 employee stock options (now exercised). |
| 01/26/2018 | Date exercisable for 23,696 employee stock options. |
| 01/25/2019 | Date exercisable for 21,834 employee stock options. |
| 01/24/2020 | Date exercisable for 41,208 employee stock options. |
| 01/24/2021 | Date exercisable for 48,309 employee stock options. |
| 01/27/2022 | Date exercisable for 38,376 employee stock options. |
| 01/24/2023 | Date exercisable for 21,997 employee stock options. |
| 01/24/2024 | Date exercisable for 22,312 employee stock options and vesting start for 1,297.11 Restricted Stock Units. |
| 01/26/2025 | Date exercisable for 24,774 employee stock options and vesting start for 2,841.16 Restricted Stock Units. |
| 10/24/2025 | Earliest transaction date; acquisition of 153.29 phantom units. |
| 10/27/2025 | Exercise of 16,672 employee stock options and sale of 14,222 shares of common stock. |
| 10/28/2025 | Signature date of the filing. |
| 01/24/2026 | Vesting end date for 1,297.11 Restricted Stock Units. |
| 01/27/2026 | Date exercisable for 24,570 employee stock options and vesting start for 4,352.99 Restricted Stock Units. |
| 05/17/2026 | Expiration date for 16,672 employee stock options (now exercised). |
| 01/26/2027 | Expiration date for 23,696 employee stock options and vesting end date for 2,841.16 Restricted Stock Units. |
| 01/25/2028 | Expiration date for 21,834 employee stock options. |
| 01/27/2028 | Vesting end date for 4,352.99 Restricted Stock Units. |
| 01/24/2029 | Expiration date for 41,208 employee stock options. |
| 01/24/2030 | Expiration date for 48,309 employee stock options. |
| 01/27/2031 | Expiration date for 38,376 employee stock options. |
| 01/24/2032 | Expiration date for 21,997 employee stock options. |
| 01/24/2033 | Expiration date for 22,312 employee stock options. |
| 01/26/2034 | Expiration date for 24,774 employee stock options. |
| 01/27/2035 | Expiration date for 24,570 employee stock options. |
Keywords
FUL, H.B. Fuller, Insider Trading, Form 4, Stock Options, RSU, Phantom Units, Executive Compensation, John J. Corkrean
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.